Bone Biologics (BBLG) Interest Coverage Ratio Growth (1y) (2015 - 2025)
Powered by 
Analysis
Bone Biologics (BBLG) Interest Coverage Ratio Growth (1y) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 93.04% |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | -25.59% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 1,170.12% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -53.46% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 99.48% |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 53.60% |
| Sep 30, 2025 | 9.72% |
| Dec 31, 2021 | -3,638.38% |
| Sep 30, 2021 | -39.94% |
| Jun 30, 2021 | -66.20% |
| Mar 31, 2021 | 45.86% |
| Dec 31, 2020 | 23.76% |
| Sep 30, 2020 | 49.29% |
| Jun 30, 2020 | 80.67% |
| Mar 31, 2020 | 75.64% |
| Dec 31, 2019 | 79.52% |
| Sep 30, 2019 | -168.19% |
| Jun 30, 2019 | -29.60% |
| Mar 31, 2019 | -78.48% |
| Dec 31, 2018 | -495.04% |
| Sep 30, 2018 | 287.07% |
| Jun 30, 2018 | -203.80% |
| Mar 31, 2018 | -8.14% |
| Sep 30, 2017 | 91.47% |
| Jun 30, 2017 | 117.13% |